Skip to main content

DISEÑO Y OBTENCION DE UN ALIMENTO FUNCIONAL BASADO EN PEPTIDOS DE ORIGEN VEGETAL CON ACTIVIDAD INMUNOESTIMULADORA Y ANTIOXIDATIVA PARA ENSAYOS IN VITRO E IN VIVO

AGL2012-40247-C02-01

•
Funding agency name Ministerio de Economía y Competitividad
Funding agency acronym MINECO
Program Programa Nacional de Proyectos de Investigación Fundamental
Subprogram Subprograma de Proyectos de Investigación Fundamental no Orientada
Call Proyectos I+D
Call year 2012
State Plan 2008-2011 Plan Nacional de Investigación Científica, Desarrollo e Innovación Tecnológica
Management unit Secretaría de Estado de Investigación, Desarrollo e Innovación
Beneficiary centre AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 9
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Safety and Efficacy of a Beverage Containing Lupine Protein Hydrolysates on the Immune, Oxidative and Lipid Status in Healthy Subjects: An Intervention Study (the Lupine-1 Trial)

  • Cruz-Chamorro, Iván
  • Álvarez-Sánchez, Nuria
  • Álvarez-Ríos, Ana Isabel
  • Santos-Sánchez, Guillermo
  • Pedroche, Justo
  • Millán, Francisco
  • Carrera Sánchez, Cecilio
  • Fernández-Pachón, María Soledad
  • Millán-Linares, María del Carmen
  • Martínez-López, Alicia
  • Lardone, Patricia Judith
  • Bejarano, Ignacio
  • Guerrero, Juan Miguel
  • Carrillo-Vico, Antonio
10 Páginas.-- 4 Figuras.-- 8 Tablas, Scope We have previously demonstrated the anti-inflammatory and antioxidant properties of in vitro administered Lupinus angustifolius protein hydrolysates (LPHs) on human peripheral blood mononuclear cells (PBMCs). This study aims to evaluate the safety and efficacy of a beverage containing LPHs (LPHb) on the immune, oxidative and metabolic status of healthy subjects. Methods and Results In this open-label intervention, 33 participants daily ingest a LPHb containing 1 g LPHs for 28 days. Biochemical parameters are assayed in fasting peripheral blood and urine samples before, during (14 days) and after LPHb ingestion. Participants’ health status and the immune and antioxidant responses of PBMCs are also evaluated throughout the trial. The LPHb ingestion is safe and effective in both increasing the anti-/pro-inflammatory response of PBMCs and improving the cellular anti-oxidant capacity. LPHb also reduces the low-density lipoprotein-cholesterol (LDL-C)/high-density lipoprotein-cholesterol (HDL-C) atherogenic index. LPHb effect is particularly beneficial on decreasing not only the LDL-C/HDL-C index but also serum total cholesterol levels in the male cohort that shows the highest baseline levels of well-known cardiovascular risk factors. Conclusion This is the first study to show the pleiotropic actions of a lupine bioactive peptides-based functional food on key steps of atherosclerosis including inflammation, oxidative stress, and cholesterol metabolism., Ministerio de Economía y Competitividad. Grant Numbers: AGL2012-40247-C02-01, AGL2012-40247-C02-02 Programa PAIDI Junta de Andalucia. Grant Number: CTS160 Ministerio de Educación, Cultura y Deporte. Grant Numbers: FPU13/01210, FPU16/02339 Ministerio de Ciencia e Innovación (Red Temática de Investigación Cooperativa en Envejecimiento y Fragilidad; RETICEF). Grant Numbers: RD06/0013/0001, RD12/0043/0012 Universidad de Sevilla. Grant Numbers: V PPIT-US, VI PPIT-US Consejería de Salud y Familias, Junta de Andalucía. Grant Number: PC-0111-2016-0111, Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Lupinus angustifolius Protein Hydrolysates Reduce Abdominal Adiposity and Ameliorate Metabolic Associated Fatty Liver Disease (MAFLD) in Western Diet Fed-ApoE−/− Mice

  • Santos-Sánchez, Guillermo
  • Cruz-Chamorro, Iván
  • Álvarez-Ríos, Ana Isabel
  • Fernández-Santos, José María
  • Vázquez-Román, María Victoria
  • Rodríguez-Ortiz, Beatriz
  • Álvarez-Sánchez, Nuria
  • Álvarez-López, Ana Isabel
  • Millán-Linares, María del Carmen
  • Millán, Francisco
  • Pedroche, Justo
  • Fernández-Pachón, María Soledad
  • Lardone, Patricia Judith
  • Guerrero, Juan Miguel
  • Bejarano, Ignacio
  • Carrillo-Vico, Antonio
15 Páginas.-- 6 Figuras.-- 1 Tabla, Metabolic-associated fatty liver disease (MAFLD) is the most important cause of liver disease worldwide. It is characterized by the accumulation of fat in the liver and is closely associated with abdominal obesity. In addition, oxidative stress and inflammation are significant features involved in MAFLD. Recently, our group demonstrated that lupin protein hydrolysates (LPHs) had lipid lowering, antioxidant, and anti-inflammatory effects. Sixty male mice fed with a Western diet were intragastrically treated with LPHs (or vehicle) for 12 weeks. Liver and adipose tissue lipid accumulation and hepatic inflammatory and oxidant status were evaluated. A significant decrease in steatosis was observed in LPHs-treated mice, which presented a decreased gene expression of CD36 and LDL-R, crucial markers in MAFLD. In addition, LPHs increased the hepatic total antioxidant capacity and reduced the hepatic inflammatory status. Moreover, LPHs-treated mice showed a significant reduction in abdominal adiposity. This is the first study to show that the supplementation with LPHs markedly ameliorates the generation of the steatotic liver caused by the intake of a Western diet and reduces abdominal obesity in ApoE−/− mice. Future clinical trials should shed light on the effects of LPHs on MAFLD., This research was funded by the Spanish Government, Ministerio de Economía y Competitividad [AGL2012-40247-C02-01 and AGL2012-40247-C02-02], the Andalusian Government Ministry of Health [PC-0111-2016-0111], and the PAIDI Program from the Andalusian Government [CTS160]. G.S.-S. and I.C.-C. were supported by FPU grants from the Spanish Ministerio de Educación, Cultura y Deporte, [FPU16/02339] and [FPU13/01210], respectively. N.Á.-S. was supported by a fellowship from the National Net RETICEF for Aging Studies (RD12/0043/0012 from the Instituto de Salud Carlos III, Spanish Ministerio de Ciencia e Innovación). B.R.-O. was supported by a grant from European Social Fund and Spanish Ministerio de Empleo y Seguridad Social [EJ-086]. A.I.Á.-L. was funded by the Andalusian Government Ministry of Health [PI-0136-2019]. I.B. was supported by the VI Program of Inner Initiative for Research and Transfer of University of Seville (VI PPIT-US)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

A Lupin (Lupinus angustifolius) Protein Hydrolysate Exerts Anxiolytic-Like Effects in Western Diet-Fed ApoE−/− Mice

  • Santos-Sánchez, Guillermo
  • Ponce-España, Eduardo
  • López, Juan Carlos
  • Álvarez-Sánchez, Nuria
  • Álvarez-López, Ana Isabel
  • Pedroche, Justo
  • Millán, Francisco
  • Millán-Linares, María del Carmen
  • Lardone, Patricia Judith
  • Bejarano, Ignacio
  • Cruz-Chamorro, Iván
  • Carrillo-Vico, Antonio
16 Páginas.-- 6 Figuras.-- 3 Tablas, Anxiety is the most prevalent psychiatric disorder worldwide, causing a substantial economic burden due to the associated healthcare costs. Given that commercial anxiolytic treatments may cause important side effects and have medical restrictions for prescription and high costs, the search for new natural and safer treatments is gaining attention. Since lupin protein hydrolysate (LPH) has been shown to be safe and exert anti-inflammatory and antioxidant effects, key risk factors for the anxiety process and memory impairment, we evaluated in this study the potential effects of LPH on anxiety and spatial memory in a Western diet (WD)-induced anxiety model in ApoE-/- mice. We showed that 20.86% of the 278 identified LPH peptides have biological activity related to anxiolytic/analgesic effects; the principal motifs found were the following: VPL, PGP, YL, and GQ. Moreover, 14 weeks of intragastrical LPH treatment (100 mg/kg) restored the WD-induced anxiety effects, reestablishing the anxiety levels observed in the standard diet (SD)-fed mice since they spent less time in the anxiety zones of the elevated plus maze (EPM). Furthermore, a significant increase in the number of head dips was recorded in LPH-treated mice, which indicates a greater exploration capacity and less fear due to lower levels of anxiety. Interestingly, the LPH group showed similar thigmotaxis, a well-established indicator of animal anxiety and fear, to the SD group, counteracting the WD effect. This is the first study to show that LPH treatment has anxiolytic effects, pointing to LPH as a potential component of future nutritional therapies in patients with anxiety., This research was funded by the Spanish Government, Ministerio de Economía y Competitividad (AGL2012-40247-C02-01, and AGL2012-40247-C02-02), the Andalusian Government Ministry of Health (PC-0111-2016-0111, and PEMP-0085-2020) and the PAIDI Program from the Andalusian Government (CTS160). G.S.-S. was supported by a FPU grant from the Spanish Ministerio de Educación, Cultura y Deporte (FPU16/02339). E.P.-E. and I.B. were supported by the VI Program of Inner Initiative for Research and Transfer of University of Seville (VI PPIT-US). I.C.-C. was supported by the VI Program of Inner Initiative for Research and Transfer of the University of Seville (VIPPIT-2020-II.4) and by a postdoctoral fellowship from the Andalusian Government Ministry of Economy, Knowledge, Business, and University (DOC_00587/2020). N.A.-S. was supported by a fellowship from the National Net RETICEF for Aging Studies (RD12/0043/0012 from the Instituto de Salud Carlos III, Spanish Ministerio de Ciencia e Innovación). A.I.Á.-L. was funded by Andalusian Government Ministry of Health (PI-0136-2019)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Bioactive Peptides from Lupin (Lupinus angustifolius) Prevent the Early Stages of Atherosclerosis in Western Diet-Fed ApoE-/- Mice

  • Santos-Sánchez, Guillermo
  • Cruz-Chamorro, Iván
  • Álvarez-Ríos, Ana Isabel
  • Álvarez-Sánchez, Nuria
  • Rodríguez-Ortiz, Beatriz
  • Álvarez-López, Ana Isabel
  • Fernández-Pachón, María Soledad
  • Pedroche, Justo
  • Millán, Francisco
  • Millán-Linares, María del Carmen
  • Lardone, Patricia Judith
  • Bejarano, Ignacio
  • Carrillo-Vico, Antonio
11 Páginas.-- 5 Figuras.-- 2 Tablas, We have previously reported the in vitro hypocholesterolemic, anti-inflammatory, and antioxidant effects of Alcalase-generated lupin protein hydrolysate (LPH). Given that lipoprotein deposition, oxidative stress, and inflammation are the main components of atherogenesis, we characterized the LPH composition, in silico identified LPH-peptides with activities related to atherosclerosis, and evaluated the in vivo LPH effects on atherosclerosis risk factors in a mouse model of atherosclerosis. After 15 min of Alcalase hydrolysis, peptides smaller than 8 kDa were obtained, and 259 peptides out of 278 peptides found showed biological activities related to atherosclerosis risk factors. Furthermore, LPH administration for 12 weeks reduced the plasma lipids, as well as the cardiovascular and atherogenic risk indexes. LPH also increased the total antioxidant capacity, decreased endothelial permeability, inflammatory response, and atherogenic markers. Therefore, this study describes for the first time that LPH prevents the early stages of atherosclerosis., Ministerio de Economía y Competitividad, Gobierno de España [AGL2012-40247-C02-01 and AGL2012-40247-C02-02], Consejería de Salud, Junta de Andalucía [PC-0111-2016-0111 and PEMP-0085-2020], and the Programa PAIDI from the Junta de Andalucía [CTS160]. G.S.-S. was supported by Formación Profesorado Universitario grants from the Ministerio de Educación, Cultura y Deporte, Gobierno de España [FPU16/02339]. I.C.-C. was supported by a postdoctoral fellowship from the Consejería de Economía, Conocimiento, Empresas y Universidad, Junta de Andalucía [DOC_00587/2020]. N.Á.-S. was supported by a fellowship from the Red Temática de Investigación Cooperativa en Envejecimiento y Fragilidad (RETICEF) [RD12/0043/0012 from the Instituto de Salud Carlos III, Ministerio de Ciencia e Innovación, Gobierno de España]. B.R.-O. was supported by a grant from the Programa de Empleo Juvenil of Ministerio de Empleo y Seguridad Social, Gobierno de España [EJ-086]. A.I.Á.-L. was funded by the Consejería de Salud, Junta de Andalucía [PI-0136-2019]. I.B. was supported by the VI Plan Propio de Investigación y Transferencia of Universidad de Sevilla [VI PPIT-US]., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Pleiotropic biological effects of Lupinus spp. protein hydrolysates

  • Cruz-Chamorro, Iván
  • Santos-Sánchez, Guillermo
  • Álvarez-López, Ana Isabel
  • Pedroche, Justo
  • Lardone, Patricia Judith
  • Arnoldi, Anna
  • Lammi, Carmen
  • Carrillo-Vico, Antonio
23 Páginas.-- 4 Figuras.-- 4 Tablas, Background: Over the last two decades, the demand for meat-free food has increased for health, environmental, and animal welfare reasons. Thus, research on the value of vegetable compounds as beneficial agents for human health has gained much attention. In particular, great interest has been shown in protein hydrolysation since this food technology facilitates the release of encrypted peptides with biological activities. In this sense, during the last 10 years, the biological activities of Lupinus spp. protein hydrolysates (LPHs) have been extensively studied. Scope and approach: The aim of this review is to address all studies (in silico, in vitro, and in vivo) in which the biological activities (antioxidant, anti-inflammatory, etc.) of LPHs were described, both the whole hydrolysate and the derived peptides. Moreover, the physicochemical characteristics of LPH peptides are evaluated, and challenges and future perspectives for their fast application have been discussed. Key findings and conclusions: LPHs exert many important biological effects in both the in vitro and in vivo systems. The main activities of LPHs described are antioxidant, immunomodulatory, hypotensive, hypoglycemic, and hypolipidemic. These findings point to LPHs as a possible new nutraceutical for human health, capable of preventing or treating some chronic diseases such as diabetes, dyslipidemia, and atherosclerosis. Finally, the development of a new generation of nanonutraceuticals to improve the metabolic stability and bioactivity of LPHs has been discussed., This work was funded by the Spanish Government, Ministerio de Economía y Competitividad (AGL2012-40247-C02-01 and AGL2012-40247-C02-02), the Andalusian Government Ministry of Health PC-0111-2016-0111, PEMP 0085–2020 (co-financed with FEDER funds, call Resolution of 7 July 2021 of the General Secretary for Research, Development and Innovation in Health, which calls for grants to finance research, development and innovation in biomedicine and health sciences in Andalusia by 2021), and the PAIDI Program from the Andalusian Government (CTS160). ICC was supported by a postdoctoral fellowship from Consejería de Transformación Económica, Industria, Conocimiento y Universidades (Junta de Andalucía) (DOC_00587/2020). GSS was supported by a FPU grant from Ministerio de Educación, Cultura y Deporte (Gobierno de España) (FPU16/02339). AIAL was funded by Consejería de Salud (Junta de Andalucía) (PI-0136-2019 and PEMP 0085–2020)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Chemical and biological characterization of the DPP-IV inhibitory activity exerted by lupin (Lupinus angustifolius) peptides: From the bench to the bedside investigation

  • Cruz-Chamorro, Iván
  • Santos-Sánchez, Guillermo
  • Bollati, Carlotta
  • Bartolomei, Martina
  • Capriotti, Anna Laura
  • Cerrato, Andrea
  • Laganà, Aldo
  • Pedroche, Justo
  • Millán, Francisco
  • Millán-Linares, María del Carmen
  • Arnoldi, Anna
  • Carrillo-Vico, Antonio
  • Lammi, Carmen
10 Páginas.-- 5 Figuras.-- 1 Tabla, Dipeptidyl peptidase IV (DPP-IV) is considered a key target for the diabetes treatment, since it is involved in glucose metabolism. Although lupin protein consumption shown hypoglycemic activity, there is no evidence of its effect on DPP-IV activity. This study demonstrates that a lupin protein hydrolysate (LPH), obtained by hydrolysis with Alcalase, exerts anti-diabetic activity by modulating DPP-IV activity. In fact, LPH decreased DPP-IV activity in a cell-free and cell-based system. Contextually, Caco-2 cells were employed to identify LPH peptides that can be intestinally trans-epithelial transported. Notably, 141 different intestinally transported LPH sequences were identified using nano- and ultra-chromatography coupled to mass spectrometry. Hence, it was demonstrated that LPH modulated the glycemic response and the glucose concentration in mice, by inhibiting the DPP-IV. Finally, a beverage containing 1 g of LPH decreased DPP-IV activity and glucose levels in humans., Ministerio de Economía y Competitividad, Gobierno de España [AGL2012-40247-C02-01 and AGL2012-40247-C02-02]. Consejería de Salud [PC-0111-2016-0111], and the PAIDI Program [CTS160] from Junta de Andalucía. I.C.-C. was supported by Ministerio de Educación, Cultura y Deporte, Gobierno de España [FPU13/01210], by the Universidad de Sevilla [VIPPIT-2020-II.4], and by a postdoctoral fellowship from the Consejería de Transformación Económica, Industria, Conocimiento y Universidades, Junta de Andalucía [DOC_00587/2020]. G.S.-S. was supported by Ministerio de Educación, Cultura y Deporte, Gobierno de España [FPU16/02339], and by an Erasmus+ Mobility Programme., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Characterisation and beneficial effects of a Lupinus angustifolius protein hydrolysate obtained by immobilisation of the enzyme alcalase®

  • Santos-Sánchez, Guillermo
  • Cruz-Chamorro, Iván
  • Márquez-López, José Carlos
  • Pedroche, Justo
  • Álvarez-López, Ana Isabel
  • Millán-Linares, María del Carmen
  • Lardone, Patricia Judith
  • Carrillo-Vico, Antonio
9 Páginas.-- 5 Figuras.-- 1 Tabla, Bioactive peptides have been considered potential components for the future functional foods and nutraceuticals generation. The enzymatic method of hydrolysis has several advantages compared to those of chemical hydrolysis and fermentation. Despite this fact, the high cost of natural and commercial proteases limits the commercialization of hydrolysates in the food and pharmacological industries. For this reason, more efficient and economically interesting techniques, such as the immobilisation of the enzyme, are gaining attention. In the present study, a new protein hydrolysate from Lupinus angustifolius was generated by enzymatic hydrolysis through the immobilisation of the enzyme alcalase® (imLPH). After the chemical and nutritional characterization of the imLPH, an in vivo study was carried out in order to evaluate the effect of 12 weeks treatment with imLPH on the plasmatic lipid profile and antioxidant status in western-diet-fed apolipoprotein E knockout mice. The immobilisation of alcalase® generated an imLPH with a degree of hydrolysis of 29.71 ± 2.11%. The imLPH was mainly composed of protein (82.50 ± 0.88%) with a high content of glycine/glutamine, arginine, and aspartic acid/asparagine. The imLPH-treatment reduced the amount of abdominal white adipose tissue, total plasma cholesterol, LDL-C, and triglycerides, as well as the cardiovascular risk indexes (CRI) -I, CRI-II, and atherogenic index of plasma. The imLPH-treated mice also showed an increase in the plasma antioxidant capacity. For the first time, this study demonstrates the beneficial in vivo effect of a lupin protein hydrolysate obtained with the alcalase® immobilised and points out this approach as a possible cost-effective solution at the expensive generation of the hydrolysate through the traditional batch conditions with soluble enzymes., Ministerio de Economía y Competitividad, Spanish Government [AGL2012-40247-C02-01 and AGL2012-40247-C02-02]; Andalusian Government Ministry of Health PC-0111-2016-0111, PEMP-0085-2020 (co-financed with FEDER funds, call Resolution of 7 July 2021 of the General Secretary for Research, Development and Innovation in Health, which calls for grants to finance research, development and innovation in biomedicine and health sciences in Andalusia by 2021) and PAIDI Program from the Andalusian Government [CTS160]. FPU grants from the Spanish Ministerio de Educación, Cultura y Deporte, [FPU16/02339] supported G. S.-S. A postdoctoral fellowship from the Andalusian Government Ministry of Economy, Knowledge, Business, and University [DOC_00587/2020] supported I. C.-C. Andalusian Government Ministry of Health [PI-0136-2019] supported A. I. A.-L. We thank the staff from the IBiS Animal Facility for their valuable assistance., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

A Lupin (Lupinus angustifolius) Protein Hydrolysate Decreases the Severity of Experimental Autoimmune Encephalomyelitis: A Preliminary Study

  • Cruz-Chamorro, Iván
  • Álvarez-López, Ana Isabel
  • Santos-Sánchez, Guillermo
  • Álvarez-Sánchez, Nuria
  • Pedroche, Justo
  • Millán-Linares, María del Carmen
  • Lardone, Patricia Judith
  • Carrillo-Vico, Antonio
Multiple sclerosis (MS) is a neurodegenerative disease, with inflammation and oxidative stress in the central nervous system being the main triggers. There are many drugs that reduce the clinical signs of MS, but none of them cure the disease. Food proteins have been shown to contain encrypted peptides that can be released after hydrolysis and exert numerous biological activities. Recently, we have demonstrated the anti-inflammatory and antioxidant activities of a lupin protein hydrolysate (LPH) both in vitro and in vivo. Therefore, the aim of this study was to evaluate whether LPH is capable of reducing the clinical signs of experimental autoimmune encephalomyelitis (EAE), a mouse model of MS. EAE was induced in female C57BL/6N mice and they were treated intragastrically with LPH (100 mg/kg) or vehicle (control group) from day 0 (prophylactic approach) or from the onset of the disease (day 12 post-induction; therapeutic approach) and the clinical score of each mouse was recorded daily. Prophylactic treatment with LPH reduced the clinical score of the mice compared to the control group, as well as the maximum and cumulative scores, without changing the day of onset of the symptoms while the therapeutic intervention did not significantly improve the severity of the disease. For the first time, we demonstrated that prophylactic administration of LPH reduces the severity of MS, suggesting a potential nutraceutical or new functional foods in neuroinflammation. However, further studies are needed to confirm this nutritional effect in a clinical context., This work was supported by the Ministerio de Economía y Competitividad, Gobierno de España (AGL2012-40247-C02); Consejería de Salud y Familias, Junta de Andalucía PC-0111-2016-0111, PC-0019-2017, and PEMP-0085-2020 (co-financed with FEDER funds, call Resolution of 7 July 2021 of the General Secretary for Research, Development and Innovation in Health, which calls for grants to finance research, development and innovation in biomedicine and health sciences in Andalusia by 2021), the PAIDI Program from the Andalusian Government (CTS160) and the National Net NutriCrop, granted by the Ministerio de Ciencia e Innovación (NutriCropRED2022-134382-T). I.C.-C. was supported by a postdoctoral fellowship from the Consejería de Economía, Conocimiento, Empresas y Universidad, Junta de Andalucía (DOC_00587/2020). A.I.Ǻ.L. was funded by the grants US-1263804 and PEMP-0085-2020. G.S.-S. was supported by Ministerio de Educación, Cultura y Deporte, Gobierno de España (FPU16/02339). N.Ǻ.-S. was supported by the Instituto de Salud Carlos III, Ministerio de Ciencia e Innovación, Gobierno de España (RETICEF, RD12/0043/0012)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Research data Set de datos (Dataset)

Dataset of Evaluation of the action of a lupine protein hydrolysate in Experimental Autoimmune Encephalomyelitis (EAE)

  • Cruz-Chamorro, Iván
  • Álvarez-López, Ana Isabel
  • Santos-Sánchez, Guillermo
  • Álvarez-Sánchez, Nuria
  • Pedroche, Justo
  • Millán-Linares, María del Carmen
  • Lardone, Patricia Judith
  • Carrillo-Vico, Antonio
The dataset includes the raw data from the weight, clinical score, and number of sequences carried out in the work titled "A lupin (Lupinus angustifolius) protein hydrolysate decreases the severity of experimental autoimmune encephalomyelitis, a preclinical model of multiple sclerosis". LPH reduced the clinical score of the mice compared to the control group, as well as the maximum and cumulative scores, without changing the day of onset of the symptoms while the therapeutic intervention did not significantly improve the severity of the disease. Fifty-six female C57BL/6N mice (8-weeks-old) from the University of Seville Animal Facility were housed under standard conditions with ad libitum access to water and food. For the induction of EAE, 100 µg of MOG35–55 peptide (Cambridge Research Biochemicals, Cambridge, UK) emulsified in complete Freud´s adjuvant (CFA) containing 4 mg/mL of heat-inactivated Mycobacterium tuberculosis (Sigma-Aldrich, St. Louis, MO, USA) was inoculated subcutaneously. Furthermore, two doses of 400 ng pertussis toxin (Enzo Life Sciences, Farmingdale, NY, USA) were administered intraperitoneally on days 0 and 2 post-induction (p.i.) to induce the disease. An EAE clinical sign score was assigned daily to each mouse as follows: 0 = no clin-ical sign; 1 = no tail tone; 2 = impaired righting reflex; 3 = paralysis of one hind limb; 4 = paralysis of both hind limbs; 5 = paralysis of both hind limbs and one forelimb; 6 = if the score was greater than 5 (including moribund or dead mouse). LPH sequencing was performed using nano high-performance liquid chromatography coupled to an Orbitrap Elite mass spectrometer. The BIOPEP-UWM database was used to identify the motifs with proven biological activity., AGL2012-40247-C02, PC-0111-2016-0111, PC-0019-2017, PEMP-0085-2020, The data set titled “LPH_EAE_Dataset.xlsx” includes numerical data from mice weight and clinical score, and the numbers of sequences with a determinate biological activity., Peer reviewed